Jude Onyia, Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,662 shares at $121.90 ($568K) on 2022-11-29, disclosed to the SEC on 2022-12-01.
Open-market sale of $568k NBIX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.90 | 2,331 | $284K | 50.0% |
| 2 | $121.90 | 2,331 | $284K | 50.0% |
| Total | $121.90 avg | 4,662 | $568K | 100% |
| Filing → |
| NBIX | SELL | 2025-07-11 | $15.6M | — | Filing → |
| NBIX | SELL | 2025-07-07 | $5.3M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $672K | — | Filing → |